We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
FUJIY Q1 Earnings Fall Y/Y on Bio CDMO Costs, Revenues Rise
Read MoreHide Full Article
Key Takeaways
FUJIFILM's Q1 earnings fell 30% as revenue rose 10.3% to a record first-quarter yen 826.5 billion.
Bio CDMO fixed costs and restructuring lowered FUJIFILM's operating income by 32% to yen 51.2 billion.
FUJIFILM raised its fiscal 2026 revenue forecast to yen 3,560 billion while maintaining its profit outlook.
FUJIFILM Holdings Corporation (FUJIY - Free Report) reported first-quarter fiscal 2026 earnings of ¥31.26 per share, down 30% year over year. Net income attributable to FUJIFILM Holdings fell 30.4% to ¥37.4 billion.
Revenues rose 10.3% to a record first-quarter ¥826.5 billion, aided by Healthcare, Electronics, Imaging and favorable currency effects. Semiconductor Materials revenue jumped 31.3%, reflecting strong AI-related demand.
FUJIY's Profitability Comes Under Pressure
Operating income declined 32% year over year to ¥51.2 billion, while the operating margin contracted to 6.2% from 10%. Higher fixed costs in Bio CDMO, one-time Business Innovation restructuring costs and rising raw material prices outweighed profit growth in Electronics and Imaging.
Gross profit increased 3.5% to ¥323.4 billion, but the gross margin fell to 39.1% from 41.7%. Selling, general and administrative expenses climbed 16.9% to ¥229.9 billion, while research and development expenses rose 4.1% to ¥42.3 billion.
FUJIFILM Healthcare Swings to a Loss
Healthcare revenues increased 12.4% to ¥256.8 billion, but the segment posted an operating loss of ¥12.7 billion versus income of ¥4.3 billion a year earlier. Medical Systems revenues rose 12.8% to ¥162.4 billion, supported by higher endoscope and medical IT sales.
Bio CDMO revenues increased 6.4% to ¥57.7 billion. Expanded large-scale operations were offset by unplanned shutdowns at small- to medium-scale U.S. facilities for regulatory inspections and upfront costs tied to the new U.S. site. LS Solutions revenues advanced 21.4% to ¥36.7 billion.
Fujifilm Holdings Corp. Price, Consensus and EPS Surprise
Electronics revenues surged 25% to ¥127.7 billion, while operating income rose 38.2% to ¥31.1 billion. The segment's operating margin expanded to 24.4% from 22.1%.
Semiconductor Materials revenues reached ¥84.9 billion as sales of CMP slurry, NTI developers, advanced photoresists and liquid polyimides benefited from AI semiconductor demand. AF Materials revenues rose to ¥42.8 billion, helped by higher data-tape sales to major IT companies.
FUJIFILM Imaging Extends Revenue Momentum
Imaging revenues advanced 16.2% to ¥168.8 billion, and operating income increased 3.9% to ¥43.4 billion. Consumer Imaging revenues climbed 25.1% to ¥96.7 billion as instax sales benefited from strong mid-to-high-priced models and expanded film supply.
Professional Imaging revenues rose 6% to ¥72.1 billion on digital-camera demand, particularly in Asia. However, revenue declined 4.6% on a constant-currency basis because of a tough comparison with strong new-product sales in the prior-year quarter.
FUJIY’s Business Innovation
Business Innovation revenues edged down 0.1% to ¥273.2 billion, while the segment recorded a ¥1.4 billion operating loss versus ¥15.6 billion of income a year ago. Office Solutions revenues fell 4.6% to ¥114.5 billion amid lower exports to Europe and the United States and weaker sales in China.
Business Solutions revenues rose 2.7% to ¥77.8 billion, while Graphic Communications revenues increased 4.1% to ¥81 billion. FUJIFILM also began assessing a partial spin-off of Business Innovation, with execution being considered within the next two to three years.
FUJIFILM Cash Flow Reflects Heavy Investment
Net cash provided by operating activities was ¥92.3 billion compared with ¥94.8 billion a year earlier. Investing activities used ¥124.9 billion, producing negative free cash flow of ¥32.6 billion.
Cash and cash equivalents ended June at ¥150.7 billion, down ¥19.9 billion from March. Total assets increased to ¥6,167.3 billion, while inventories rose ¥66.3 billion to ¥667.1 billion.
FUJIY Raises Revenue Outlook, Keeps Profit View
FUJIFILM raised its fiscal 2026 revenue forecast by ¥90 billion to ¥3,560 billion, representing 6% growth from fiscal 2025. The company maintained its operating income forecast at ¥365 billion and net income outlook at ¥280 billion, implying increases of 4.2% and 1.2%, respectively.
Healthcare operating income guidance was cut to ¥41 billion from ¥69 billion because of delayed Bio CDMO profitability. Electronics operating income guidance was raised to ¥120 billion from ¥106 billion, while Business Innovation was lifted to ¥80 billion from ¥65 billion. Imaging remained at ¥162 billion.
Recent Performance of Other Companies in Tech Space
Fortive Corporation (FTV - Free Report) reported second-quarter 2026 adjusted earnings of 74 cents per share, which jumped 28.5% year over year and topped the Zacks Consensus Estimate of 71 cents by 4.2%.
Revenues rose 7.9% year over year to $1.10 billion and beat the consensus estimate of $1.06 billion by 3.5%. Core revenues increased 6.7%, reflecting price and volume growth in both operating segments.
Flex Ltd. (FLEX - Free Report) reported first-quarter fiscal 2027 adjusted earnings of $1.00 per share, up 38.9% year over year. The figure beat the Zacks Consensus Estimate of 93 cents by 7.5%.
Revenues advanced 20.6% to $7.93 billion and topped the consensus mark of $7.58 billion by 4.6%. Broad-based segment growth, led by a 35% expansion in Cloud and Power Infrastructure, supported the results.
SAP SE (SAP - Free Report) reported second-quarter 2026 non-IFRS earnings per share of €1.59 ($1.85), which increased 6% from the year-ago quarter. The Zacks Consensus Estimate was pegged at $2.
Despite macroeconomic uncertainty, SAP reported total revenues on a non-IFRS basis of €9.9 billion ($11.5 billion), which increased 9% year over year (up 11% at constant currency or cc). The Zacks Consensus Estimate was pegged at $11.4 billion.
View the Zacks #1 Rank List
Image: Bigstock
FUJIY Q1 Earnings Fall Y/Y on Bio CDMO Costs, Revenues Rise
Key Takeaways
FUJIFILM Holdings Corporation (FUJIY - Free Report) reported first-quarter fiscal 2026 earnings of ¥31.26 per share, down 30% year over year. Net income attributable to FUJIFILM Holdings fell 30.4% to ¥37.4 billion.
Revenues rose 10.3% to a record first-quarter ¥826.5 billion, aided by Healthcare, Electronics, Imaging and favorable currency effects. Semiconductor Materials revenue jumped 31.3%, reflecting strong AI-related demand.
FUJIY's Profitability Comes Under Pressure
Operating income declined 32% year over year to ¥51.2 billion, while the operating margin contracted to 6.2% from 10%. Higher fixed costs in Bio CDMO, one-time Business Innovation restructuring costs and rising raw material prices outweighed profit growth in Electronics and Imaging.
Gross profit increased 3.5% to ¥323.4 billion, but the gross margin fell to 39.1% from 41.7%. Selling, general and administrative expenses climbed 16.9% to ¥229.9 billion, while research and development expenses rose 4.1% to ¥42.3 billion.
FUJIFILM Healthcare Swings to a Loss
Healthcare revenues increased 12.4% to ¥256.8 billion, but the segment posted an operating loss of ¥12.7 billion versus income of ¥4.3 billion a year earlier. Medical Systems revenues rose 12.8% to ¥162.4 billion, supported by higher endoscope and medical IT sales.
Bio CDMO revenues increased 6.4% to ¥57.7 billion. Expanded large-scale operations were offset by unplanned shutdowns at small- to medium-scale U.S. facilities for regulatory inspections and upfront costs tied to the new U.S. site. LS Solutions revenues advanced 21.4% to ¥36.7 billion.
Fujifilm Holdings Corp. Price, Consensus and EPS Surprise
Fujifilm Holdings Corp. price-consensus-eps-surprise-chart | Fujifilm Holdings Corp. Quote
FUJIY Electronics Leads Segment Profit Growth
Electronics revenues surged 25% to ¥127.7 billion, while operating income rose 38.2% to ¥31.1 billion. The segment's operating margin expanded to 24.4% from 22.1%.
Semiconductor Materials revenues reached ¥84.9 billion as sales of CMP slurry, NTI developers, advanced photoresists and liquid polyimides benefited from AI semiconductor demand. AF Materials revenues rose to ¥42.8 billion, helped by higher data-tape sales to major IT companies.
FUJIFILM Imaging Extends Revenue Momentum
Imaging revenues advanced 16.2% to ¥168.8 billion, and operating income increased 3.9% to ¥43.4 billion. Consumer Imaging revenues climbed 25.1% to ¥96.7 billion as instax sales benefited from strong mid-to-high-priced models and expanded film supply.
Professional Imaging revenues rose 6% to ¥72.1 billion on digital-camera demand, particularly in Asia. However, revenue declined 4.6% on a constant-currency basis because of a tough comparison with strong new-product sales in the prior-year quarter.
FUJIY’s Business Innovation
Business Innovation revenues edged down 0.1% to ¥273.2 billion, while the segment recorded a ¥1.4 billion operating loss versus ¥15.6 billion of income a year ago. Office Solutions revenues fell 4.6% to ¥114.5 billion amid lower exports to Europe and the United States and weaker sales in China.
Business Solutions revenues rose 2.7% to ¥77.8 billion, while Graphic Communications revenues increased 4.1% to ¥81 billion. FUJIFILM also began assessing a partial spin-off of Business Innovation, with execution being considered within the next two to three years.
FUJIFILM Cash Flow Reflects Heavy Investment
Net cash provided by operating activities was ¥92.3 billion compared with ¥94.8 billion a year earlier. Investing activities used ¥124.9 billion, producing negative free cash flow of ¥32.6 billion.
Cash and cash equivalents ended June at ¥150.7 billion, down ¥19.9 billion from March. Total assets increased to ¥6,167.3 billion, while inventories rose ¥66.3 billion to ¥667.1 billion.
FUJIY Raises Revenue Outlook, Keeps Profit View
FUJIFILM raised its fiscal 2026 revenue forecast by ¥90 billion to ¥3,560 billion, representing 6% growth from fiscal 2025. The company maintained its operating income forecast at ¥365 billion and net income outlook at ¥280 billion, implying increases of 4.2% and 1.2%, respectively.
Healthcare operating income guidance was cut to ¥41 billion from ¥69 billion because of delayed Bio CDMO profitability. Electronics operating income guidance was raised to ¥120 billion from ¥106 billion, while Business Innovation was lifted to ¥80 billion from ¥65 billion. Imaging remained at ¥162 billion.
Zacks Rank & Price Performance of FUJIY
Currently, FUJIFILM has a Zacks Rank #3 (Hold). In the past year, shares have lost 6.8% against the Zacks Semiconductor Equipment – Photomasks industry’s growth of 57.9%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Image Source: Zacks Investment Research
Recent Performance of Other Companies in Tech Space
Fortive Corporation (FTV - Free Report) reported second-quarter 2026 adjusted earnings of 74 cents per share, which jumped 28.5% year over year and topped the Zacks Consensus Estimate of 71 cents by 4.2%.
Revenues rose 7.9% year over year to $1.10 billion and beat the consensus estimate of $1.06 billion by 3.5%. Core revenues increased 6.7%, reflecting price and volume growth in both operating segments.
Flex Ltd. (FLEX - Free Report) reported first-quarter fiscal 2027 adjusted earnings of $1.00 per share, up 38.9% year over year. The figure beat the Zacks Consensus Estimate of 93 cents by 7.5%.
Revenues advanced 20.6% to $7.93 billion and topped the consensus mark of $7.58 billion by 4.6%. Broad-based segment growth, led by a 35% expansion in Cloud and Power Infrastructure, supported the results.
SAP SE (SAP - Free Report) reported second-quarter 2026 non-IFRS earnings per share of €1.59 ($1.85), which increased 6% from the year-ago quarter. The Zacks Consensus Estimate was pegged at $2.
Despite macroeconomic uncertainty, SAP reported total revenues on a non-IFRS basis of €9.9 billion ($11.5 billion), which increased 9% year over year (up 11% at constant currency or cc). The Zacks Consensus Estimate was pegged at $11.4 billion.